Company intelligence / Profile preview

Clearview Capital

Stamford, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Clearview Capital is a private investment firm focused on acquiring and recapitalizing lower-middle-market companies in North America. The firm is not a biotechnology, pharmaceutical, or healthcare operating company; rather, it is a financial sponsor that invests across multiple industries, including selected healthcare services businesses. In healthcare, Clearview has emphasized provider services and non-reimbursement healthcare segments rather than drug development. The firm was founded in 1999 and is headquartered in Stamford, Connecticut, with additional offices in California, North Carolina, and Ohio. For a biotech analyst, Clearview is best understood as a private equity owner and capital partner, not as a therapeutic-product developer with an R&D pipeline.

Industry: Investors

Beyond the preview

Go deeper on Clearview Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clearview Capital.

Explore the full profile